Ulrik Fahnøe

1.6k citations

71 papers · 1.0k indexed · 1 hit paper · h-index 17

Hepatology top 2%
- Hepatitis C virus research 31
Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 20
- Viral gastroenteritis research and epidemiology 12
- COVID-19 Clinical Research Studies 11
Animal Science and Zoology top 5%
- Animal Virus Infections Studies 13
Agronomy and Crop Science top 5%
- Animal Disease Management and Epidemiology 13
Epidemiology top 10%
- Hepatitis B Virus Studies 28
- Liver Disease Diagnosis and Treatment 17

Co-authors: Jens Bukh Santseharay Ramírez Judith M. Gottwein Long V. Pham Anna Offersgaard Carlota Fernandez-Antunez Karen Anbro Gammeltoft Yuyong Zhou
Cited by: Hepatology Infectious Diseases Animal Science and Zoology
Partner nations: Denmark United States Germany

In The Last Decade

Ulrik Fahnøe

65 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

Peers

Countries citing papers authored by Ulrik Fahnøe

Since Specialization

Citations

This map shows the geographic impact of Ulrik Fahnøe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrik Fahnøe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrik Fahnøe more than expected).

Fields of papers citing papers by Ulrik Fahnøe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrik Fahnøe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrik Fahnøe. The network helps show where Ulrik Fahnøe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ulrik Fahnøe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulrik Fahnøe Line = papers co-authored together Ulrik Fahnøe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance Carlota Fernandez-Antunez,Line A. Ryberg,Kuan Wang,Long V. Pham,Lotte S. Mikkelsen,Ulrik Fahnøe,Katrine Top Hartmann,Henrik Elvang Jensen,Kenn Holmbeck,Jens Bukh,Santseharay Ramírez	2025	0
2	Norway rat hepacivirus resembles hepatitis C virus in terms of intra-host evolution and escape from neutralizing antibodies Caroline E. Thorselius,Raphael Wolfisberg,Ulrik Fahnøe,Troels K. H. Scheel,Kenn Holmbeck,Jens Bukh	2025	0
3	An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals Anna Offersgaard,Carlos R. Duarte Hernandez,Yuyong Zhou,Z. H. Duan,Karen Anbro Gammeltoft,Katrine Top Hartmann,Ulrik Fahnøe,Pavel Marichal‐Gallardo,Garazi Peña Alzua,Alexander P. Underwood,Christina Sølund,Nina Weis,Jesper Bonde,Jan Pravsgaard Christensen,Gabriel Kristian Pedersen,Henrik Elvang Jensen,Kenn Holmbeck,Jens Bukh,Judith M. Gottwein	2024	1
4	Prevalence of HCV HVR1 insertions and their role in antibody evasion Christina Holmboe Olesen,Laura Collignon,Rodrigo Velázquez‐Moctezuma,Margherita Fanalista,Ulrik Fahnøe,Sarah Mollerup,Uffe Vest Schneider,Kenn Holmbeck,Jens Bukh,Jannick Prentoe	2024	0
5	Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients Ulrik Fahnøe,Lone Wulff Madsen,Peer Brehm Christensen,Christina Sølund,Sarah Mollerup,Mette Pinholt,Nina Weis,Anne Øvrehus,Jens Bukh	2024	1
6	Pre‐existing, treatment‐specific resistance‐associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct‐acting antivirals Christina Sølund,Martin Schou Pedersen,Ulrik Fahnøe,Jonathan Filskov,Håvard Jenssen,Nina Weis,Kristian Schønning,Jens Bukh	2023	3
7	A Distinct Dexamethasone-Dependent Gene Expression Profile in the Lungs of COVID-19 Patients Ulrik Fahnøe,Andreas Ronit,Ronan M. G. Berg,Sofie E. Jørgensen,Trine H. Mogensen,Alexander P. Underwood,Troels K. H. Scheel,Jens Bukh,Ronni R. Plovsing	2022	6
8	Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture systembreakdown → Yuyong Zhou,Karen Anbro Gammeltoft,Line A. Ryberg,Long V. Pham,Helena D. Tjørnelund,Alekxander Binderup,Carlos Rene Duarte Hernandez,Carlota Fernandez-Antunez,Anna Offersgaard,Ulrik Fahnøe,Günther H. Peters,Santseharay Ramírez,Jens Bukh,Judith M. Gottwein	2022	132
9	Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization Long V. Pham,Rodrigo Velázquez‐Moctezuma,Ulrik Fahnøe,Laura Collignon,Priyanka Shukla Bajpai,Christina Sølund,Nina Weis,Kenn Holmbeck,Jannick Prentoe,Jens Bukh	2022	2
10	Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication Ulrik Fahnøe,Long V. Pham,Carlota Fernandez-Antunez,Rui Costa,Lizandro R. Rivera-Rangel,Andrea Galli,Shan Feng,Lotte S. Mikkelsen,Judith M. Gottwein,Troels K. H. Scheel,Santseharay Ramírez,Jens Bukh	2022	24
11	Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro Yuyong Zhou,Karen Anbro Gammeltoft,Andrea Galli,Anna Offersgaard,Ulrik Fahnøe,Santseharay Ramírez,Jens Bukh,Judith M. Gottwein	2021	24
12	Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication Santseharay Ramírez,Carlota Fernandez-Antunez,Andrea Galli,Alexander P. Underwood,Long V. Pham,Line A. Ryberg,Shan Feng,Martin Schou Pedersen,Lotte S. Mikkelsen,Sandrine Belouzard,Jean Dubuisson,Christina Sølund,Nina Weis,Judith M. Gottwein,Ulrik Fahnøe,Jens Bukh	2021	63
13	Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro Karen Anbro Gammeltoft,Yuyong Zhou,Carlos R. Duarte Hernandez,Andrea Galli,Anna Offersgaard,Rui Costa,Long V. Pham,Ulrik Fahnøe,Shan Feng,Troels K. H. Scheel,Santseharay Ramírez,Jens Bukh,Judith M. Gottwein	2021	37
14	High recombination rate of hepatitis C virus revealed by a green fluorescent protein reconstitution cell system Andrea Galli,Ulrik Fahnøe,Jens Bukh	2021	2
15	Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity Niels Mejer,Ulrik Fahnøe,Andrea Galli,Santseharay Ramírez,Ola Weiland,Thomas Benfield,Jens Bukh	2020	8
16	Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent Niels Mejer,Andrea Galli,Santseharay Ramírez,Ulrik Fahnøe,Thomas Benfield,Jens Bukh	2019	8
17	HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape Long V. Pham,Sanne B. Jensen,Ulrik Fahnøe,Martin Schou Pedersen,Qi Tang,Lubna Ghanem,Santseharay Ramírez,Daryl Humes,Stéphanie B. N. Serre,Kristian Schønning,Jens Bukh,Judith M. Gottwein	2018	32
18	A near full-length open reading frame next generation sequencing assay for genotyping and identification of resistance-associated variants in hepatitis C virus Martin Schou Pedersen,Ulrik Fahnøe,T. A. Hansen,Anders Gorm Pedersen,Håvard Jenssen,Jens Bukh,Kristian Schønning	2018	8
19	Mouse models of acute and chronic hepacivirus infection Eva Billerbeck,Raphael Wolfisberg,Ulrik Fahnøe,Jing Xiao,Corrine Quirk,Joseph M. Luna,John M. Cullen,Alex S. Hartlage,Luis Chiriboga,Kalpana Ghoshal,W. Ian Lipkin,Jens Bukh,Troels K. H. Scheel,Amit Kapoor,Charles M. Rice	2017	94
20	Sequence adaptations during growth of rescued classical swine fever viruses in cell culture and within infected pigs Johanne Hadsbjerg,Martin Friis,Ulrik Fahnøe,Jens Peter Nielsen,Graham J. Belsham,Thomas Bruun Rasmussen	2016	3

About Ulrik Fahnøe

Ulrik Fahnøe is a scholar working on Hepatology, Infectious Diseases and Agronomy and Crop Science, having authored 71 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (28 papers), SARS-CoV-2 and COVID-19 Research (20 papers), Liver Disease Diagnosis and Treatment (17 papers), Animal Virus Infections Studies (13 papers), Animal Disease Management and Epidemiology (13 papers), Viral gastroenteritis research and epidemiology (12 papers) and COVID-19 Clinical Research Studies (11 papers). The work is most often cited by research in Hepatology (305 citations), Infectious Diseases (494 citations) and Animal Science and Zoology (154 citations). Ulrik Fahnøe has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Jens Bukh, Santseharay Ramírez, Judith M. Gottwein, Long V. Pham, Anna Offersgaard, Carlota Fernandez-Antunez, Karen Anbro Gammeltoft, Yuyong Zhou, Shan Feng and Andrea Galli.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact